HCA Healthcare, Inc. — Cyborg Score 7/10

Solid
For-profit hospital operators and acute care networks

Strategic Profile

HCA maintains a strong competitive position through scale, geographic diversification, and centralized operational discipline. The company balances volume growth with margin expansion, leveraging its large footprint to optimize supply chain costs, staffing efficiency, and payer negotiations while investing in digital health and patient care improvements.

Cyborg Score Rationale

HCA demonstrated resilience in Q1 2026 with 4.3% revenue growth to $19.1B and 10.9% EPS growth despite a challenging volume environment marked by lower respiratory admissions. Strong cash generation (up 22% YoY) and consistent margin performance (12% operating margin) reflect operational strength, though modest same-facility admissions growth (0.9%) and seasonal volume headwinds indicate a maturing market.

Top Insights

  • (April 2026) Q1 2026 revenues reached $19.1B with 4.3% YoY growth; net income of $1.6B and EPS of $7.15 (+10.9% YoY)
  • (April 2026) Operating cash flow surged 22% to $2.0B despite atypical absence of seasonal volume growth, indicating underlying operational strength
  • (April 2026) Medicaid supplemental programs bolstered results, partially offsetting 42% decline in respiratory-related admissions and winter weather impacts
  • (January 2026) Full-year 2025 saw strong performance with Q4 net income up 30.6% and Adjusted EBITDA up 10.8%, with 2.4% same-facility admission growth

Named Competitors

  • Tenet Healthcare — For-profit hospital network operator with ~65 hospitals
  • Community Health Systems — For-profit hospital chain with ~100 hospitals
  • Cleveland Clinic — Non-profit integrated health system, major regional competitor
  • UnitedHealth/Optum — Integrated insurance and healthcare services platform

Recent Developments

  • (April 2026) Q1 2026 earnings: $19.1B revenue (+4.3%), $1.6B net income, $3.8B Adjusted EBITDA
  • (March 2026) Board declared $0.78 per share quarterly dividend
  • (January 2026) FY2025 results showed strong momentum with 6.7% revenue growth to $19.5B in Q4, driving full-year guidance expectations

Open the full interactive HCA Healthcare, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →